Stereotaxis, Inc., a pioneering leader in the field of robotic-assisted cardiac interventions, is headquartered in the United States. Founded in 2004, the company has established itself as a key player in the medical technology industry, particularly in the development of advanced robotic systems for the treatment of arrhythmias. Stereotaxis is renowned for its innovative Niobe® and Odyssey® systems, which utilise magnetic navigation to enhance precision and safety during complex cardiac procedures. This unique approach not only improves patient outcomes but also streamlines the workflow for healthcare professionals. With a strong presence in major operational regions across North America and Europe, Stereotaxis continues to achieve significant milestones, solidifying its market position as a trusted provider of cutting-edge solutions in electrophysiology.
How does Stereotaxis, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Stereotaxis, Inc.'s score of 28 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Stereotaxis, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Stereotaxis may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As the company does not inherit emissions data from a parent organisation, it operates independently in terms of climate reporting. Without specific emissions figures or reduction initiatives, Stereotaxis, Inc. remains unaccounted for in the context of corporate climate commitments within its industry.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Stereotaxis, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

